|
|
| Issue Open | Apr 30, 2018 |
| Issue Close | May 3, 2018 |
| IPO Price | ₹51 |
| Face Value | ₹10 |
| IPO Size | ₹7.29 Cr |
| Listing At | BSE SME |
| IPO Lot Size | 2000 |
Fri, 06 Aug 2021 05:19:00 GMT
Here's a roundup of top developments in the biotech space over the last 24 hours ... use authorization of its vaccine in India, Indonesia and the Philippines. The company announced second ...
Tue, 21 Sep 2021 10:00:00 GMT
The portfolio value of Sangel Capital ("Sangel" or the "Company"), a leading biotech and healthcare venture capital company based in China, is poised for strong growth as multiple biotech and ...
Thu, 19 Aug 2021 02:33:00 GMT
SINGAPORE (Reuters) - Indonesia's biggest tech group GoTo is set to complete a pre-IPO funding exercise to raise up to $2 billion in the next few weeks, but regulatory delays threaten to push its ...
Wed, 22 Sep 2021 18:45:00 GMT
This is why LinkedIn’s list of Top Startups 2021 serves as a source of encouragement and hope. To put together this year’s rankings, LinkedIn accessed their data across four pillars: employee growth, ...
Wed, 15 Sep 2021 02:00:00 GMT
Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, today announced the appointment of Lars R. Boesgaard as Chief Financial Officer (CFO), effective ...
Mon, 30 Aug 2021 16:59:00 GMT
In other words, the companies are not receiving IPO cash to foster growth - like for innovation or expansion. Then there are the surefire Wall Street money machines of SPAC funds, "biotech ...
Sun, 12 Sep 2021 17:00:00 GMT
Mergers and acquisitions (M&A) deals picked up steam throughout Asia Pacific during the first half of 2021, in no small measure due to a rebound from the worst economic ravages of the COVID-19 ...
Mon, 13 Sep 2021 07:51:00 GMT
Meris DDoS proving difficult to stop. REvil has apparently returned. Chinese operators hit Indonesia's government (including its principal intelligence service). DPRK's preparatory charm offensive. Al ...
Thu, 09 Sep 2021 08:13:00 GMT
Following the launch of Razer’s first smartphone, Tan listed the firm in Hong Kong in November 2017, raising US$529 million. The IPO then made him the youngest ... which focuses on biotech, agri-tech, ...
Sun, 05 Sep 2021 17:00:00 GMT
Cheng said the group had recently inked a three-year distribution deal worth US$200,000 (RM829,300) annually with a customer in Taiwan for livestock biotech products developed in-house.
Wed, 15 Sep 2021 23:46:00 GMT
Stock prices in London are seen cautiously opening higher, despite a weak handover from Asia, though economic uncertainty is keeping a lid on gains. In early UK corporate news, equipment rental firm ...
The IPO Shares of Indo US Bio-Tech Limited IPO are proposed to list on Friday, May 11, 2018 at BSE SME. The public issue of Indo US BioTech IPO was opened on Apr 30, 2018 and closed for subscription on May 3, 2018. Indo US BioTech IPO Listing Date and Information:
The allotment status of Indo US Bio-Tech Limited IPO is now available online. The public issue of Indo US BioTech IPO was open on Apr 30, 2018 and closed for subscription on May 3, 2018. The equity shares of the company to be list at BSE SME.
The issue of Indo US Bio-Tech Limited opens on Apr 30, 2018 and closes for subscription on May 3, 2018. The equity shares of the company to be list at BSE SME. The price for the issue has been set at Rs 51 Per Equity Share.
Indo US Bio-Tech Limited is entering in the capital market with an IPO of 1,430,000 Equity Shares of Rs 10 aggregating up to Rs 72.93 Crore. The price for the issue has been set at Rs 51 Per Equity Share.
Incorporated in 2004, Gujarat based Indo US Bio-Tech Limited is engaged in the business of breeding products, processing and marketing of high performing open-pollinated and hybrid agricultural seed varieties & (seed testing, soil & water testing ). The company has its own laboratory for seed testing at Junagadh.
The issue opens on Apr 30, 2018 and closes for subscription on May 4, 2018. The equity shares of the company to be list at BSE SME.
The Indo US BioTech IPO is proposed to open on Apr 30, 2018. The IPO application ends on May 3, 2018.
Retail investors can apply in the retail or non-institutional investor category from Apr 30, 2018 to May 3, 2018. The Indo US BioTech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Indo US BioTech IPO will open for subscription on Apr 30, 2018. The public issue will close on May 3, 2018.
Useful Articles
Rs 0 Eq Delivery Brokerage
Flat ₹10 Per Trade in F&O
Rs 0 Demat AMC
